Barriers to Hepatitis C Treatment among Women in Methadone Treatment: A Study from Iran, the Most Populous Persian Gulf Country.

Massah, Omid; Effatpanah, Mohammad; Moradi, Afsaneh; Salehi, Mohammad; Farhoudian, Ali; Karami, Zahra

Massah, Omid; Effatpanah, Mohammad; Moradi, Afsaneh; Salehi, Mohammad; Farhoudian, Ali; Karami, Zahra.

Afiliação

Massah O; PhD Student, Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Effatpanah M; Psychiatrist, Assistant Professor, Ziaeian Hospital, Tehran University of Medical Sciences, Tehran , Iran.
Moradi A; PhD Student, Department of Psychology, School of Psychology and Educational Sciences, Al-Zahra University, Tehran, Iran.
Salehi M; PhD Student, Department of Neurosciences and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Farhoudian A; Associate Professor, Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Karami Z; Department of Counseling, School of Psychology and Educational Sciences, Allameh Tabataba'i University, Tehran, Iran.

Addict Health ; 9(4): 229-236, 2017.

Article em En | MEDLINE | ID: mdl-30574286

Palavras-chave

Drugs; Hepatitis C virus; Iran; Methadone; Treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Qualitative_research Idioma: En Revista: Addict Health Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google